EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protection Conferred by Gallid Alphaherpesvirus 2 Vaccines Against Immunosuppression Induced by Very Virulent Plus (vv+) Marek’s Disease Virus Strains in Commercial Meat Type Chickens

Nagwa Khaled, Carissa Gaghan iD, Abdelhamid M Fares iD, Christa Goodell iD, William Stanley, Raveendra R Kulkarni iD, Isabel M Gimeno

Pathogens · 2025

DOI: 10.3390/pathogens14010054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Nagwa Khaled und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA. Hauptthemen laut MEDLINE: Marek Disease, Herpesvirus 2, Gallid, Poultry Diseases, Viral Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education of the Arab Republic of Egypt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Very virulent plus Marek’s disease virus (vv+MDV) induces severe immunosuppression in commercial chickens. In this study, we evaluated how three Gallid alphaherpesvirus 2 (GaHV-2) vaccines (CVI-988, rMd5-BAC∆Meq, and CVI-LTR) protected against two negative outcomes of vv+MDV infection: (1) reduced viability and frequency of immune cells in the spleen and (2) decreased efficacy of the CEO (chicken embryo origin) vaccine against infectious laryngotracheitis challenge. At 25 days post-infection with vv+MDV 686, all vaccines are protected against the reduced viability of splenocytes. However, there were differences in the frequency of splenic immunophenotypes among groups. Compared to the uninfected control, the frequency of B cells was reduced in the CVI-988/686 group but not in the rMd5-BAC∆Meq/686 and CVI-LTR/686 groups. T cell subset frequencies showed no difference between the negative controls and CVI-988/686; however, there was a reduction in activated CD4+ T cells in the rMd5-BAC∆Meq/686 group and in activated CD4+, activated CD8+, and γδ+ T cells in the CVI-LTR/686 group. We also demonstrated that the three vaccines protected against MDV-induced tumors, but only rMd5-BAC∆Meq and CVI-LTR protected against the negative impact of vv+MDV 648A strain on CEO vaccine efficacy. Our findings demonstrate important differences in the biology and/or mechanisms of protection of these vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Marek DiseaseHerpesvirus 2, GallidPoultry DiseasesViral VaccinesImmune ToleranceMarek Disease VaccinesAnimalsChickensSpleen

Stichwörter der Autor:innen

CEOCVI-988CVI-LTRILTMDVchickensimmunosuppressionrMd5-BAC∆Meq

Substanzen

Viral VaccinesMarek Disease Vaccines

Autor:innen und Institutionen

  • College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607, USA.
  • Faculty of Veterinary Medicine, University of Sadat City, El Sadat City 6011007, Menofia Governorate, Egypt.
  • Boehringer Ingelheim Animal Health USA Inc., Duluth, GA 30096, USA.

ORCID-Profile: Carissa Gaghan, Abdelhamid M Fares, Christa Goodell, Raveendra R Kulkarni

Förderung

  • Ministry of Higher Education of the Arab Republic of Egypt

Zitieren

APA

Khaled, N., Gaghan, C., Fares, A. M., Goodell, C., Stanley, W., Kulkarni, R. R., & Gimeno, I. M. (2025). Protection Conferred by Gallid Alphaherpesvirus 2 Vaccines Against Immunosuppression Induced by Very Virulent Plus (vv+) Marek’s Disease Virus Strains in Commercial Meat Type Chickens. Pathogens. https://doi.org/10.3390/pathogens14010054

Vancouver

Khaled N, Gaghan C, Fares AM, Goodell C, Stanley W, Kulkarni RR, et al. Protection Conferred by Gallid Alphaherpesvirus 2 Vaccines Against Immunosuppression Induced by Very Virulent Plus (vv+) Marek’s Disease Virus Strains in Commercial Meat Type Chickens. Pathogens. 2025. doi:10.3390/pathogens14010054

BibTeX
@article{Khaled2025,
  author = {Khaled, Nagwa and Gaghan, Carissa and Fares, Abdelhamid M and Goodell, Christa and Stanley, William and Kulkarni, Raveendra R and Gimeno, Isabel M},
  title = {Protection Conferred by Gallid Alphaherpesvirus 2 Vaccines Against Immunosuppression Induced by Very Virulent Plus (vv+) Marek’s Disease Virus Strains in Commercial Meat Type Chickens},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14010054}
}
Kostenlos starten →